ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORTnewsfilecorp.com
Palantir Stock Is 2,500% More Expensive Than the S&P 500 Average. History Is Clear About What Happens Next.fool.com
INO FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - INOnewsfilecorp.com
Exclusive: Tesla in talks with Chinese firms to buy $2.9 bln worth of solar equipment, sources sayreuters.com